Back to Search
DAPHNE HAAS-KOGAN, M.D.
M.D.
Radiation Oncology Physician
NPI: 1366484248IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
G76324(CA)262630(MA)
Education
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
EGFR signals to mTOR through PKC and independently of Akt in glioma.
PMID 19176518·Sci Signal·2009
8-other
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
PMID 19171716·J Clin Oncol·2009
4-observational
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
PMID 19075262·J Clin Oncol·2009
3-trial
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
PMID 18937318·Pediatr Blood Cancer·2009
3-trial
Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.
PMID 19410386·Int J Radiat Oncol Biol Phys·2009
8-other
p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.
PMID 19074867·Cancer Res·2008
7-preclinical
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
PMID 18417739·Neuro Oncol·2008
3-trial
Nutrient-sensitive, antagonistically pleiotropic genes and their contribution to malignant behavior.
PMID 17689876·Med Hypotheses·2008
7-preclinical
Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.
PMID 18413797·Mol Cancer Ther·2008
7-preclinical
Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
PMID 18485615·Int J Radiat Oncol Biol Phys·2008
8-other
Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal.
PMID 17352019·World J Gastroenterol·2007
8-other
AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines.
PMID 17346876·Cancer Lett·2007
8-other
Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
PMID 17517478·Int J Radiat Oncol Biol Phys·2007
8-other
Glioma invasiveness responds variably to irradiation in a co-culture model.
PMID 17889268·Int J Radiat Oncol Biol Phys·2007
8-other
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
PMID 17347490·Neuro Oncol·2007
7-preclinical
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
PMID 17504928·Neuro Oncol·2007
8-other
The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
PMID 16502348·Invest New Drugs·2006
4-observational
The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.
PMID 16495375·Neuro Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 732-5500
Quick Facts
- NPI
- 1366484248
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile